Exenatide in Extreme Pediatric Obesity

NCT01237197 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

University of Minnesota

Collaborators

[object Object]